Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Intuitive Surgical, Inc. (ISRG), featuring income statements, balance sheets, and cash flow data.
Intuitive Surgical, Inc. (ISRG) Income Statement & Financial Overview
Analyze Intuitive Surgical, Inc.’s ISRG earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.25B | $2.41B | $2.04B | $2.010B |
| Cost of Revenue | $795.70M | $771.30M | $664.20M | $637.20M |
| Gross Profit | $1.46B | $1.64B | $1.37B | $1.37B |
| Gross Profit Ratio | $0.65 | $0.68 | $0.67 | $0.68 |
| R&D Expenses | $316.20M | $294.70M | $286.00M | $280.10M |
| SG&A Expenses | $563.40M | $612.60M | $510.60M | $525.30M |
| Operating Expenses | $879.60M | $907.30M | $796.60M | $805.40M |
| Total Costs & Expenses | $1.68B | $1.68B | $1.46B | $1.44B |
| Interest Income | $90.40M | $74.90M | $93.70M | $87.20M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $140.90M | $124.70M | $116.20M | $111.80M |
| EBITDA | $719.00M | $859.60M | $693.50M | $679.10M |
| EBITDA Ratio | $0.32 | $0.36 | $0.34 | $0.34 |
| Operating Income | $578.10M | $734.90M | $577.30M | $567.30M |
| Operating Income Ratio | $0.26 | $0.30 | $0.28 | $0.28 |
| Other Income/Expenses (Net) | $90.40M | $74.90M | $93.70M | $87.20M |
| Income Before Tax | $668.50M | $809.80M | $671.00M | $654.50M |
| Income Before Tax Ratio | $0.30 | $0.34 | $0.33 | $0.33 |
| Income Tax Expense | -$35.20M | $121.80M | $100.40M | $123.00M |
| Net Income | $698.40M | $685.70M | $565.10M | $526.90M |
| Net Income Ratio | $0.31 | $0.28 | $0.28 | $0.26 |
| EPS | $1.95 | $1.92 | $1.59 | $1.48 |
| Diluted EPS | $1.92 | $1.88 | $1.56 | $1.46 |
| Weighted Avg Shares Outstanding | $357.50M | $356.40M | $355.80M | $355.00M |
| Weighted Avg Shares Outstanding (Diluted) | $364.60M | $363.90M | $362.70M | $361.00M |
Financial performance has remained strong, with revenue growing from $2.010B in Q2 2024 to $2.25B in Q1 2025. Gross profit continued to perform well, with margins at 65% in the latest quarter. Operating income reached $578.10M in Q1 2025, holding a steady 26% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $719.00M. Net income rose to $698.40M, keeping EPS at $1.95. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan